"Immunodominant Epitopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody.
Concept/Terms
Immunodominant Epitopes- Immunodominant Epitopes
- Immunodominant Determinants
- Determinants, Immunodominant
- Immunodominant Domains
- Domains, Immunodominant
- Immunodominant Sites
- Sites, Immunodominant
- Immunodominant Regions
- Regions, Immunodominant
- Antigenic Determinants, Immunodominant
- Determinants, Immunodominant Antigenic
- Immunodominant Antigenic Determinants
- Epitopes, Immunodominant
Below are MeSH descriptors whose meaning is more general than "Immunodominant Epitopes".
Below are MeSH descriptors whose meaning is more specific than "Immunodominant Epitopes".
This graph shows the total number of publications written about "Immunodominant Epitopes" by people in Harvard Catalyst Profiles by year, and whether "Immunodominant Epitopes" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 3 | 2 | 5 |
| 1995 | 1 | 5 | 6 |
| 1996 | 4 | 1 | 5 |
| 1997 | 5 | 4 | 9 |
| 1998 | 2 | 2 | 4 |
| 1999 | 3 | 3 | 6 |
| 2000 | 4 | 5 | 9 |
| 2001 | 4 | 3 | 7 |
| 2002 | 5 | 3 | 8 |
| 2003 | 1 | 6 | 7 |
| 2004 | 6 | 4 | 10 |
| 2005 | 3 | 9 | 12 |
| 2006 | 4 | 5 | 9 |
| 2007 | 6 | 4 | 10 |
| 2008 | 1 | 5 | 6 |
| 2009 | 1 | 1 | 2 |
| 2010 | 4 | 3 | 7 |
| 2011 | 3 | 2 | 5 |
| 2012 | 3 | 3 | 6 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 3 | 5 |
| 2022 | 1 | 1 | 2 |
Below are the most recent publications written about "Immunodominant Epitopes" by people in Profiles.
-
The CD4+ T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease. Immunity. 2022 10 11; 55(10):1909-1923.e6.
-
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy. Blood Adv. 2022 08 23; 6(16):4859-4872.
-
Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization. Front Immunol. 2021; 12:737973.
-
HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody. Bioorg Med Chem Lett. 2021 11 01; 51:128341.
-
HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV. Cell Rep. 2021 07 13; 36(2):109378.
-
Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus. Front Immunol. 2021; 12:638485.
-
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Invest. 2021 04 01; 131(7).
-
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity. 2020 11 17; 53(5):1095-1107.e3.
-
Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study. Front Immunol. 2020; 11:2000.
-
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells. Clin Cancer Res. 2020 02 01; 26(3):679-689.